Xiaofan Wu Selected Research

Thrombosis (Thrombus)

1/2022	In-hospital outcomes of Ticagrelor versus Clopidogrel in high bleeding risk patients with acute coronary syndrome: Findings from the CCC-ACS project.
1/2018	Meta-analysis and systematic review of intravascular ultrasound versus angiography-guided drug eluting stent implantation in left main coronary disease in 4592 patients.
5/2011	The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
9/2010	Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.
1/2010	Virtual histology intravascular ultrasound analysis of non-culprit attenuated plaques detected by grayscale intravascular ultrasound in patients with acute coronary syndromes.
1/2010	Long-term (4-year) outcomes and predictors of adverse cardiac events after sirolimus-eluting stent implantation in unprotected left main coronary artery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaofan Wu Research Topics

Disease

6	Myocardial Infarction 01/2022 - 09/2010
6	Thrombosis (Thrombus) 01/2022 - 01/2010
4	Acute Coronary Syndrome 02/2022 - 11/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2010
2	Hemorrhage 02/2022 - 01/2022
2	Inflammation (Inflammations) 01/2016 - 12/2014
2	ST Elevation Myocardial Infarction 01/2013 - 09/2010
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Tibial Fractures (Fracture, Tibial) 01/2022
1	Pancreatitis 01/2022
1	Multiple Organ Failure (MODS) 01/2022
1	Ischemic Stroke 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 09/2019
1	Non-ST Elevated Myocardial Infarction 01/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019
1	Reperfusion Injury 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Death (Near-Death Experience) 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2017
1	Anemia 10/2016
1	Edema (Dropsy) 10/2016
1	Sleepiness 12/2015
1	Rhinosinusitis 12/2014
1	Hyperplasia 04/2012
1	Infarction (Infarctions) 05/2011
1	Hypertension (High Blood Pressure) 01/2011
1	Dyslipidemias (Dyslipidemia) 01/2011
1	Calcinosis 01/2010

Drug/Important Bio-Agent (IBA)

2	TicagrelorIBA 02/2022 - 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Therapeutic UsesIBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Clopidogrel (Plavix)FDA Link 01/2022
1	AntigensIBA 09/2019
1	CarbohydratesIBA 09/2019
1	Indicators and Reagents (Reagents)IBA 09/2019
1	Tumor Biomarkers (Tumor Markers)IBA 09/2019
1	MAP Kinase Kinase Kinase 5IBA 11/2017
1	Carrier Proteins (Binding Protein)IBA 11/2017
1	Phosphotransferases (Kinase)IBA 11/2017
1	Threonine (L-Threonine)FDA Link 11/2017
1	macitentanIBA 10/2016
1	ambrisentan FDA Link 10/2016
1	Bosentan (Tracleer)FDA Link 10/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2016
1	Bortezomib (Velcade)FDA Link 01/2016
1	Malondialdehyde (Propanedial)IBA 12/2015
1	Advanced Oxidation Protein Products (AOPP)IBA 12/2015
1	Enterotoxins (Enterotoxin)IBA 12/2014
1	C-Reactive ProteinIBA 01/2011
1	MetalsIBA 09/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2010
1	MB Form Creatine KinaseIBA 01/2010
1	Sirolimus (Rapamycin)FDA Link 01/2010
1	CholesterolIBA 01/2010
1	Cystatin CIBA 11/2009

Therapy/Procedure

7	Stents 01/2022 - 01/2010
4	Percutaneous Coronary Intervention 02/2022 - 01/2010
2	Length of Stay 01/2022 - 01/2019
1	Therapeutics 01/2022
1	Plasma Exchange 01/2022
1	Operative Surgical Procedures 01/2022
1	Ischemic Postconditioning 01/2019
1	Drug-Eluting Stents 01/2018